← Back to Search

Psycho-education & Understanding Bipolar Medications Therapy + MBSR + ISRT + Bipolar-Specific CBT for Bipolar Disorder

N/A
Recruiting
Led By Dorian Lamis, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Bipolar Disorder (BD)
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention, post-intervention (up to six weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how to better treat bipolar patients who are suicidal by looking at environmental and psychological factors, as well as implementing a 6-week intervention program.

Who is the study for?
This trial is for English-speaking individuals with Bipolar Disorder who can consent to participate. It's not suitable for those with cognitive impairments, organic diseases, dementia, severe substance disorders, acute psychosis, or schizophrenia spectrum disorders.
What is being tested?
The study tests a 6-week group intervention program that includes Psycho-education & Understanding Bipolar Medications Therapy, Mindfulness-Based Stress Reduction (MBSR), Interpersonal and Social Rhythm Therapy (ISRT), and Bipolar-Specific Cognitive Behavioral Therapy (CBT).
What are the potential side effects?
While this trial focuses on psychological therapies rather than medications, participants may experience emotional discomfort or distress as they confront personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Bipolar Disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention, post-intervention (up to six weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention, post-intervention (up to six weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acquired Capability for Suicide Scale (ACSS) Score
Change in Altman Self-Rating Mania Scale (ASRM) Score
Change in Beck Scale for Suicide Ideation (BSS) Score
+6 more
Secondary study objectives
Change in the Demographic Data Form Answers

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Group Intervention ProgramExperimental Treatment4 Interventions
Patients diagnosed with Bipolar Disorder will receive therapy in a group setting of 4 to 12 male and female participants.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-Based Stress Reduction (MBSR)
2018
Completed Phase 2
~1450

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,700 Previous Clinical Trials
2,604,468 Total Patients Enrolled
3 Trials studying Substance Abuse
849 Patients Enrolled for Substance Abuse
Dorian Lamis, PhDPrincipal Investigator - Emory University
Emory University

Media Library

Bipolar-Specific Cognitive Behavioral Therapy (CBT) Clinical Trial Eligibility Overview. Trial Name: NCT02604277 — N/A
Substance Abuse Research Study Groups: Group Intervention Program
Substance Abuse Clinical Trial 2023: Bipolar-Specific Cognitive Behavioral Therapy (CBT) Highlights & Side Effects. Trial Name: NCT02604277 — N/A
Bipolar-Specific Cognitive Behavioral Therapy (CBT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02604277 — N/A
~13 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top